, Tracking Stock Market Picks
Enter Symbol:
Merck & Company, Inc. (MRK) [hlAlert]

up 28.05 %

Merck & Company, Inc. (MRK) upgraded to Buy by BofA/Merrill

Posted on: Monday,  Mar 4, 2013  8:25 AM ET by BofA/Merrill

BofA/Merrill rated Buy Merck & Company, Inc. (NYSE: MRK) on 03/04/2013, when the stock price was $42.91. Since
then, Merck & Company, Inc. has gained 28.06% as of 12/01/2015's recent price of $54.95.
If you would have followed this BofA/Merrill's recommendation on MRK, you would have gained 28.05% of your investment in 1002 days.

Merck & Co., Inc. is a global research-driven pharmaceutical company that discovers, develops, manufactures and markets a broad range of human and animal health products, directly and through its joint ventures, and provides pharmaceutical benefit services through Merck-Medco Managed Care, L.L.C. Its operations are principally managed on a products and services basis and are comprised of two reportable segments: Merck Pharmaceutical and Merck-Medco.

Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/4/2013 8:25 AM Buy
as of 12/13/2013
1 Week down  -2.04 %
1 Month up  2.19 %
3 Months up  1.23 %
1 YTD up  12.74 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/24/2012 8:25 AM Hold

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy